Oppenheimer & Co. Inc. Has $10.02 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oppenheimer & Co. Inc. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 13.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,223 shares of the medical equipment provider's stock after buying an additional 2,438 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Intuitive Surgical were worth $10,016,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Castleark Management LLC grew its holdings in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. FourThought Financial Partners LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $1,158,000. Longbow Finance SA bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $4,431,000. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $454,000. Finally, Whalerock Point Partners LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $209,000. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Truist Financial reduced their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Evercore ISI lowered their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Barclays cut their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $1.45 during mid-day trading on Wednesday, hitting $521.63. The company's stock had a trading volume of 1,177,810 shares, compared to its average volume of 1,669,916. The company has a market cap of $186.96 billion, a PE ratio of 76.49, a P/E/G ratio of 5.55 and a beta of 1.67. The company's fifty day simple moving average is $530.03 and its 200-day simple moving average is $536.86. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the previous year, the firm earned $1.50 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now directly owns 907 shares of the company's stock, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last quarter. Company insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.